Marktgröße und Marktanteil von im Krankenhaus erworbenen Infektionsdiagnostika bis 2025 – 2031
Hospital Acquired Infections Diagnostics Market Report Analysis
Hospital Acquired Infections Diagnostics Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Abbott Laboratories
- AdvanDX
- Alere Inc.
- AstraZeneca Plc
- Becton Dickinson and Company
- Hologic, Inc
- Bayer Schering Pharma LLC
- Cepheid Inc
- Roche AG
Regional Overview
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika
Market Segmentation
By Produkt
- Instrumente und Reagenzien
- Verbrauchsmaterialien
By Testtyp
- Molekulare Diagnostik
- Urinanalyse
- Immunoassay
By Anwendung
- Krankheitstests
- Arzneimittelresistenztests
By Infektionstyp
- im Krankenhaus erworbene Lungenentzündung
- Blutkreislaufinfektionen
- Infektionen an der Operationsstelle
- gastrointestinale Infektionen
- andere
Get Free Sample For